KLBF.JK
Kalbe Farma Tbk PT
Price:  
1,505 
IDR
Volume:  
20,593,200
Indonesia | Pharmaceuticals

KLBF.JK WACC - Weighted Average Cost of Capital

The WACC of Kalbe Farma Tbk PT (KLBF.JK) is 12.6%.

The Cost of Equity of Kalbe Farma Tbk PT (KLBF.JK) is 12.6%.
The Cost of Debt of Kalbe Farma Tbk PT (KLBF.JK) is 5%.

RangeSelected
Cost of equity11.5% - 13.7%12.6%
Tax rate22.7% - 22.9%22.8%
Cost of debt5.0% - 5.0%5%
WACC11.5% - 13.6%12.6%
WACC

KLBF.JK WACC calculation

CategoryLowHigh
Long-term bond rate6.6%7.1%
Equity market risk premium7.9%8.9%
Adjusted beta0.620.69
Additional risk adjustments0.0%0.5%
Cost of equity11.5%13.7%
Tax rate22.7%22.9%
Debt/Equity ratio
0.010.01
Cost of debt5.0%5.0%
After-tax WACC11.5%13.6%
Selected WACC12.6%

KLBF.JK's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for KLBF.JK:

cost_of_equity (12.60%) = risk_free_rate (6.85%) + equity_risk_premium (8.40%) * adjusted_beta (0.62) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.